Hearts for Hearing

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Hearts for Hearing sits in the upper half of US sponsors by registered trial count (#4,885 of 15,742 sponsors by registered trial count).

2 total trials 2 currently recruiting upper half by trial count

Hearts for Hearing: 2 sponsored US clinical trials, 2 recruiting.

Hearts for Hearing sponsors 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting. The most-studied condition in this pipeline is Cochlear Implant, with 2 trials.

Mid-pack sponsor footprint

Hearts for Hearing is in the upper half of sponsors by trial count (#4,885 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Open and recent trials

2 total, page 1 of 1

RECRUITING

Binaural Cue Sensitivity in Children and Adults With Combined Electric and Acoustic Stimulation

NCT07356128
RECRUITING NA

Combined Electric and Acoustic Hearing (EAS) in Children and Adults

NCT05923203

Therapeutic Areas

Cochlear Implant 2
Electric and Acoustic Simulation 1
Hearing Preservation 1
Bilateral Sensorineural Hearing Loss 1
Hearing Loss 1

What is open in the Hearts for Hearing pipeline

2 recruiting of 2 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Cochlear Implant (2 trials), 4 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Hearts for Hearing: open-pipeline peers nationwide

Peers matched on 2 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Hearts for Hearing sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1.522.533.544.5 0%50%100%150% Total trials Recruiting share Hearts for Hearing1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
Hearts for Hearing sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Hearts for Hearing sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 2 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Hearts for Hearing page

2 registered trials is a research-attention snapshot, not an endorsement of Hearts for Hearing or any single study.

  • 2 of Hearts for Hearing's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Cochlear Implant is the condition Hearts for Hearing studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cochlear Implant trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Hearts for Hearing pipeline card: 2 registered trials from official public datasets.Report a data error.